FDA Clears Seven-Lead ECG Patch for Outpatient Cardiac Telemetry
The seven-lead patch enables continuous, real-time ECG monitoring for up to 14 days with immediate arrhythmia alerts to clinicians.
Read MoreThe seven-lead patch enables continuous, real-time ECG monitoring for up to 14 days with immediate arrhythmia alerts to clinicians.
Read MoreThe stent significantly improved chest pain, quality of life, and coronary microvascular function in patients in a phase 2 clinical trial.
Read MoreThe single-device solution combines pulsed field ablation therapy and advanced mapping for treating drug-refractory paroxysmal atrial fibrillation.
Read MoreThe acquisition will complement Boston Scientific’s electrophysiology portfolio with an FDA-cleared solution to advance the treatment of complex atrial fibrillation.
Read MoreResearchers have developed an optimized electrophysiological model showing that heart defibrillation can be achieved with much lower energy than current methods used.
Read More